These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6251702)

  • 1. Specific antibodies to viruses HL-23 and BILN in the blood plasma of patients with acute myelogenous leukaemia and with potential preleukaemia.
    Tóth FD; Kiss J; Váczi L; Madár Z; Jakó J; Rák K
    Acta Microbiol Acad Sci Hung; 1980; 27(2):147-53. PubMed ID: 6251702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on antigens of C-type primate viruses and antibodies to them at patients with myeloid leukemia and potentially preleukemic hematological disorders.
    Váczi L; Tóth FD
    Arch Geschwulstforsch; 1980; 50(8):769-77. PubMed ID: 6261716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and humoral cytotoxicity in patients with leukaemia and preleukaemia. II. Oncovirus specificity of the reaction.
    Szabó B; Tóth FD; Váczi L; Réthy A; Kiss A; Rák K
    Acta Microbiol Hung; 1984; 31(4):365-72. PubMed ID: 6085606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on antibodies reactive with glycoproteins of primate type C viruses in patients with myeloid leukemias and with potential preleukemia.
    Tóth FD; Váczi L; Réthy A; Szabó B; Kiss J; Kiss A; Rák K
    Neoplasma; 1982; 29(4):397-401. PubMed ID: 6290914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic activity of lymphocyte subpopulations against autologous tumour cells in patients with myeloid leukaemias and preleukaemic disorders.
    Szabó B; Váczi L; Tóth FD; Kiss J; Kiss A; Rák K
    Acta Microbiol Hung; 1988; 35(1):25-33. PubMed ID: 3260709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrovirus-neutralizing antibodies in AML and AMMoL patients: stage-specific distribution.
    Kiss J; Tóth FD; Szabó B; Kiss A; Rák K
    Neoplasma; 1989; 36(2):191-7. PubMed ID: 2716923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the specificity of human antibodies reacting with GP70 and P15 antigens of baboon endogenous (BaEV) and gibbon ape leukaemia (GaLV) viruses.
    Tóth FD; Váczi L; Szabó B; Réthy A; Rák K; Kiss J; Kiss A
    Acta Virol; 1984 May; 28(3):191-7. PubMed ID: 6147994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inability to demonstrate lytic antibodies to autologous leukaemia cells in the sera from remission patients with acute myelogenous leukaemia treated with active specific immunotherapy.
    Chapuis BJ; Powles R; Alexander P
    Clin Exp Immunol; 1978 May; 32(2):253-8. PubMed ID: 276431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of oncornavirus antigens in peripheral leucocytes of patients with chronic myeloid leukaemia.
    Tóth FD; Madár Z; Kiss J; Jakó J; Váczi L; Rák K
    Acta Microbiol Acad Sci Hung; 1979; 26(1):47-53. PubMed ID: 290130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular "labyrinths" in acute leukaemia. Do they indicate the maturational ability of leukaemic cells?
    Lelkes G; Kelkes GY; Natonek K; Hollán SR
    Haematologia (Budap); 1981; 14(3):293-306. PubMed ID: 6276273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity of lymphocytes and antibodies against autologous tumor cells in patients with myeloid leukemias and preleukemic disorders. I. Blocking activity of gp70 antigens of primate type C viruses.
    Szabó B; Tóth FD; Váczi L; Réthy A; Kiss A; Rák K
    Neoplasma; 1983; 30(2):129-35. PubMed ID: 6302527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of lymphocytes and antibodies against autologous tumor cells in patients with myeloid leukaemias and preleukaemic disorders. III. Stage-dependence of oncovirus-specific immune response.
    Szabó B; Tóth FD; Váczi L; Kiss J; Réthy A; Kiss A; Rák K
    Acta Microbiol Hung; 1986; 33(2):103-10. PubMed ID: 3492851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Disturbances in iron utilization in acute leukemia and preleukemia].
    Boewer C
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):805-10. PubMed ID: 1713886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpretation of interleukin-2 receptor alpha positive cells during induction chemotherapy for adult acute myelogenous leukaemia patients.
    Min WS; Kim HJ; Choi Y; Jeong HY; Kim CC
    Hematol Oncol; 2007 Jun; 25(2):76-83. PubMed ID: 17200986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The occurrence of antibodies against single-stranded DNA in the sera of patients with acute and chronic leukaemia.
    Izui S; Lambert PH; Carpentier N; Miescher PA
    Clin Exp Immunol; 1976 Jun; 24(3):379-84. PubMed ID: 780020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia.
    Zhu YM; Foroni L; McQuaker IG; Papaioannou M; Haynes A; Russell HH
    Br J Cancer; 1999 Mar; 79(7-8):1151-7. PubMed ID: 10098750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B and C viruses, human T-cell lymphotropic virus types I and II, and leukemias: a case-control study. The Italian Leukemia Study Group.
    Gentile G; Mele A; Monarco B; Vitale A; Pulsoni A; Visani G; Castelli G; Rapicetta M; Verani P; Martino P; Mandelli F
    Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):227-30. PubMed ID: 8833624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
    Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.
    Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schweiger C; Nuessler V; Schmid C; Kolb HJ; Schmetzer HM
    Scand J Immunol; 2005 Jul; 62(1):86-98. PubMed ID: 16091128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.